Q1 2025 Holdings
Filed 2025-05-15 | 111 holdings | $4.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $10.6M | 1,014,611 | 0.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $10.9M | 6,830,300 | 0.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $11.3M | 652,028 | 0.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $11.6M | 481,065 | 0.3% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $12.5M | 12,048,773 | 0.3% |
| Pfizer Inc(PFE)Call | COM | 717081103 | $12.7M | 500,000 | 0.3% |
| Amgen Inc(AMGN) | COM | 031162100 | $13.8M | 44,200 | 0.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $13.9M | 3,087,462 | 0.3% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $14.6M | 1,923,855 | 0.3% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $14.6M | 2,248,249 | 0.3% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $15.9M | 6,059,528 | 0.4% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $16.0M | 13,135,260 | 0.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $16.3M | 1,752,831 | 0.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $17.3M | 2,862,448 | 0.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $18.6M | 2,285,400 | 0.4% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $20.1M | 5,779,071 | 0.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $20.1M | 380,000 | 0.5% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $20.5M | 758,566 | 0.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $20.9M | 7,562,971 | 0.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $22.1M | 6,943,654 | 0.5% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $22.1M | 197,500 | 0.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $29.4M | 679,816 | 0.7% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $29.5M | 4,002,887 | 0.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $31.3M | 1,432,300 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $31.8M | 947,877 | 0.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $33.5M | 999,000 | 0.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $33.6M | 653,743 | 0.8% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $34.4M | 73,114,592 | 0.8% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $34.8M | 5,693,589 | 0.8% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $38.8M | 3,704,959 | 0.9% |
| Neuropace Inc(NPCE) | COM | 641288105 | $41.9M | 3,406,335 | 1.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $41.9M | 950,200 | 1.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $42.5M | 22,362,850 | 1.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $45.1M | 386,700 | 1.1% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $48.3M | 3,442,853 | 1.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $53.5M | 1,812,886 | 1.3% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $56.0M | 3,027,328 | 1.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $60.5M | 2,471,994 | 1.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $60.7M | 1,509,205 | 1.4% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $62.5M | 465,000 | 1.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $64.2M | 129,000 | 1.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $70.2M | 1,415,020 | 1.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $76.6M | 2,540,136 | 1.8% |
| Natera Inc(NTRA) | COM | 632307104 | $77.4M | 547,000 | 1.8% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $77.5M | 159,900 | 1.8% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $78.2M | 662,500 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $93.5M | 346,100 | 2.2% |
| Pfizer Inc(PFE) | COM | 717081103 | $97.6M | 3,850,200 | 2.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $103.4M | 934,640 | 2.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $104.3M | 8,288,510 | 2.5% |